Lymphoblast Oxidative Stress Genes as Potential Biomarkers of Disease Severity and Drug Effect in Friedreich's Ataxia.
There is no current approved therapy for the ultimately lethal neuro- and cardio-degenerative disease Friedreich's ataxia (FA). Finding minimally-invasive molecular biomarkers of disease progression and drug effect could support smaller, shorter clinical trials. Since we and others have noted a...
Príomhchruthaitheoirí: | Genki Hayashi, Gino Cortopassi |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
Public Library of Science (PLoS)
2016-01-01
|
Sraith: | PLoS ONE |
Rochtain ar líne: | http://europepmc.org/articles/PMC4831832?pdf=render |
Míreanna comhchosúla
Míreanna comhchosúla
-
Sexual dimorphism in a mouse model of Friedreich’s ataxia with severe cardiomyopathy
de réir: Lili Salinas, et al.
Foilsithe / Cruthaithe: (2024-10-01) -
Potential biomarker identification for Friedreich's ataxia using overlapping gene expression patterns in patient cells and mouse dorsal root ganglion.
de réir: Marissa Z McMackin, et al.
Foilsithe / Cruthaithe: (2019-01-01) -
Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich's Ataxia.
de réir: Mittal Jasoliya, et al.
Foilsithe / Cruthaithe: (2019-01-01) -
Genetics and Friedreich Ataxia
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (2002-06-01) -
Genetics of Friedreich Ataxia
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (1997-06-01)